mark merritt on cnbc to discuss drug pricing
Published 7 years ago • 11K plays • Length 5:35Download video MP4
Download video MP3
Similar videos
-
2:47
mark merritt: pbms 'negotiate lower drug costs'
-
3:48
the pullback in chip stocks, particularly asml, is 'overdone,' says cantor fitzgerald's muse
-
5:04
mark merritt on strategies for prevention of america's opioid epidemic
-
4:31
markham: chance for tech stocks to bounce back strongly from recent pullback
-
2:19
still very bullish that we're in a 3-5 year tech bull market, says deepwater's gene munster
-
4:00
here's how drug rebates work
-
7:41
mark merritt: addressing the opioid epidemic through existing technology
-
5:08
mag 7 likely to continues gains over next year, says samantha mclemore
-
6:14
there is not a single swing voter left in the 2024 election, says pollster frank luntz
-
7:14
special report: major computer outages occur worldwide
-
4:16
inside pharma's blame game
-
2:56
merck ceo on us healthcare system and drug pricing
-
4:19
cantor's louise chen breaks down new medicare drug pricing negotiations
-
4:57
buy on pullback and volatility, say icapital's anastasia amoroso
-
1:17
how prescription drug rebates reduce costs
-
2:25
doj orders teva and glenmark to pay millions in fines in drug price fixing settlment
-
2:44
abbott labs ceo on q2 earnings
-
4:01
citizens financial ceo on q2 earnings
-
2:54
president trump proposes change to medicare drug prices
-
1:17
how does drug pricing work?
-
4:33
inflation is not sufficiently priced into bond markets, says mark asset management's morris mark